Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Gangliosidosis GM1 type 3

Gangliosidosis GM1 type 3: Introduction

Gangliosidosis GM1 type 3: A rare biochemical disorder involving a deficiency of an enzyme (beta-galactosidase A) which results in the accumulation of harmful chemicals (GM1 gangliosides) in the central nervous system and other body tissues. Type III involves a lesser degree of accumulation than type II or I. More detailed information about the symptoms, causes, and treatments of Gangliosidosis GM1 type 3 is available below.

Symptoms of Gangliosidosis GM1 type 3

Home Diagnostic Testing

Home medical testing related to Gangliosidosis GM1 type 3:

Wrongly Diagnosed with Gangliosidosis GM1 type 3?

Gangliosidosis GM1 type 3: Complications

Read more about complications of Gangliosidosis GM1 type 3.

Causes of Gangliosidosis GM1 type 3

Read more about causes of Gangliosidosis GM1 type 3.

Disease Topics Related To Gangliosidosis GM1 type 3

Research the causes of these diseases that are similar to, or related to, Gangliosidosis GM1 type 3:

Gangliosidosis GM1 type 3: Undiagnosed Conditions

Commonly undiagnosed diseases in related medical categories:

Misdiagnosis and Gangliosidosis GM1 type 3

Vitamin B12 deficiency under-diagnosed: The condition of Vitamin B12 deficiency is a possible misdiagnosis of various conditions, such as multiple sclerosis (see symptoms of multiple sclerosis). See symptoms of...read more »

Gangliosidosis GM1 type 3: Research Doctors & Specialists

Research related physicians and medical specialists:

Other doctor, physician and specialist research services:

Statistics for Gangliosidosis GM1 type 3

Gangliosidosis GM1 type 3: Broader Related Topics

User Interactive Forums

Read about other experiences, ask a question about Gangliosidosis GM1 type 3, or answer someone else's question, on our message boards:

Definitions of Gangliosidosis GM1 type 3:

A ganglioside storage disorder caused by beta-galactosidase (EC 3.2.1.23) deficiency with resulting accumulation of excessive amounts of ganglioside GM1 in the brain tissue with less severe abnormalities than those seen in other gangliosidoses and inconsistent phenotype. Onset takes place in late teens or early adult life with cerebellar dysfunction, visual problems, and coarsening of facial features. Intellectual impairment is mild at first but intelligence tends to deteriorate in time. - (Source - Diseases Database)

Gangliosidosis GM1 type 3 is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Gangliosidosis GM1 type 3, or a subtype of Gangliosidosis GM1 type 3, affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)

Related Gangliosidosis GM1 type 3 Info

Videos about Gangliosidosis GM1 type 3

 

More information about Gangliosidosis GM1 type 3

  1. Gangliosidosis GM1 type 3: Introduction
  2. Symptoms
  3. Causes
  4. Treatments
  5. Misdiagnosis
  6. Home Testing
  7. Complications
 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise